Observational studyESC heart failure2026
Rationale and design of the Pre-MYO project: a precision-medicine platform for myocarditis diagnosis and management.
Observational study in ESC heart failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Myocardial immune vulnerability unmasked after treatment with immune checkpoint inhibitors: a case report.European heart journal. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
introductionMyocarditis is an inflammatory disease characterized by a wide spectrum of clinical presentations, which complicates its diagnosis and management. The Precision Biomarkers for Diagnosis and Management of Myocardial Inflammatory Diseases (Pre-MYO) project aims to address three major gaps: (i) the limited knowledge regarding the epidemiology, clinical management and prognosis; (ii) the absence of specific and widely accessible biomarkers able to provide an early diagnosis (precision medicine); (iii) the lack of biomarkers of susceptibility to myocarditis, including risk of recurrence and disease severity (personalized medicine). STUDY
designThe Pre-MYO is a prospective, observational and multicentre nationwide project designed to enrol 3000 patients with suspected myocarditis or inflammatory cardiomyopathy based on clinical findings. The registry includes extensive clinical characterization and long-term follow-up, including biobanks of blood samples, DNA, and cardiac magnetic resonance imaging (CMR). The platform will enable the investigation and validation of novel diagnostic and prognostic biomarkers, including the candidate hsa-RNA-Chr8:96, and the development of clinical trials. Predisposition studies will be conducted to investigate environmental and immune factors, genetic mutations, and acquired variants-including methylation analyses-that contribute to individual predisposition and risk. DISCUSSION: The Pre-MYO project will establish a collaborative research framework aimed at improving the understanding and clinical management of myocarditis by integrating precision and personalized medicine approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.